Literature DB >> 31047906

Signaling in the microenvironment of pancreatic cancer: Transmitting along the nerve.

Noelle Jurcak1, Lei Zheng2.   

Abstract

Pancreatic ductal adenocarcinoma (PDA) is a dismal malignant disease with the lowest stage-combined overall survival rate compared to any other cancer type. PDA has a unique tumor microenvironment (TME) comprised of a dense desmoplastic reaction comprising over two-thirds of the total tumor volume. The TME is comprised of cellular and acellular components that all orchestrate different signaling mechanisms together to promote tumorigenesis and disease progression. Particularly, the neural portion of the TME has recently been appreciated in PDA progression. Neural remodeling and perineural invasion (PNI), the neoplastic invasion of tumor cells into nerves, are common adverse histological characteristics of PDA associated with a worsened prognosis and increased cancer aggressiveness. The TME undergoes dramatic neural hypertrophy and increased neural density that is associated with many signaling pathways to promote cell invasion. PNI is also considered one of the main routes for cancer recurrence and metastasis after surgical resection, which remains the only current cure for PDA. Recent studies have shown multiple cell types in the TME signal through autocrine and paracrine mechanisms to enhance perineural invasion, pancreatic neural remodeling and disease progression in PDA. This review summarizes the current findings of the signaling mechanisms and cellular and molecular players involved in neural signaling in the TME of PDA.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neural remodeling; Pancreatic ductal adenocarcinoma; Perineural invasion; Tumor microenvironment

Year:  2019        PMID: 31047906      PMCID: PMC6626552          DOI: 10.1016/j.pharmthera.2019.04.010

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  97 in total

1.  Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment.

Authors:  Corina Kim-Fuchs; Caroline P Le; Matthew A Pimentel; David Shackleford; Davide Ferrari; Eliane Angst; Frédéric Hollande; Erica K Sloan
Journal:  Brain Behav Immun       Date:  2014-03-17       Impact factor: 7.217

2.  GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.

Authors:  Shu Z Wiley; Krishna Sriram; Wenjing Liang; Sarah E Chang; Randall French; Thalia McCann; Jason Sicklick; Hiroshi Nishihara; Andrew M Lowy; Paul A Insel
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

Review 3.  Stromal biology of pancreatic cancer.

Authors:  Gerald C Chu; Alec C Kimmelman; Aram F Hezel; Ronald A DePinho
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

4.  Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.

Authors:  Yaqing Zhang; Wei Yan; Meredith A Collins; Filip Bednar; Sabita Rakshit; Bruce R Zetter; Ben Z Stanger; Ivy Chung; Andrew D Rhim; Marina Pasca di Magliano
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

5.  The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.

Authors:  Federica Marchesi; Lorenzo Piemonti; Giuseppe Fedele; Annarita Destro; Massimo Roncalli; Luca Albarello; Claudio Doglioni; Achille Anselmo; Andrea Doni; Paolo Bianchi; Luigi Laghi; Alberto Malesci; Luigi Cervo; Marialuisa Malosio; Michele Reni; Alessandro Zerbi; Valerio Di Carlo; Alberto Mantovani; Paola Allavena
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

6.  Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis.

Authors:  Ihsan Ekin Demir; Stephan Schorn; Elisabeth Schremmer-Danninger; Kun Wang; Timo Kehl; Nathalia A Giese; Hana Algül; Helmut Friess; Güralp O Ceyhan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

7.  Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features.

Authors:  Linjuan Zeng; Yubo Guo; Jianzhong Liang; Shaojie Chen; Peijian Peng; Qiubo Zhang; Hong Su; Yinting Chen; Kaihong Huang
Journal:  J Cancer       Date:  2014-10-22       Impact factor: 4.207

8.  MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.

Authors:  Linjun Wang; Xiaofei Zhi; Yi Zhu; Qun Zhang; Weizhi Wang; Zheng Li; Jie Tang; Jiwei Wang; Song Wei; Bowen Li; Jianping Zhou; Jianguo Jiang; Li Yang; Hao Xu; Zekuan Xu
Journal:  Oncotarget       Date:  2015-10-20

9.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.

Authors:  C Y Chung; H P Erickson
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway.

Authors:  Liang Han; Jiguang Ma; Wanxing Duan; Lun Zhang; Shuo Yu; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Zheng Wu; Jason H Huang; Erxi Wu; Qingyong Ma; Zhenhua Ma
Journal:  Oncotarget       Date:  2016-04-05
View more
  12 in total

1.  Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.

Authors:  Hao Su; Chen Chang; Jiajie Hao; Xin Xu; Mandula Bao; Shou Luo; Chuanduo Zhao; Qian Liu; Xishan Wang; Zhixiang Zhou; Haitao Zhou
Journal:  Onco Targets Ther       Date:  2020-11-11       Impact factor: 4.147

2.  Oridonin induces autophagy-mediated cell death in pancreatic cancer by activating the c-Jun N-terminal kinase pathway and inhibiting phosphoinositide 3-kinase signaling.

Authors:  Xin Zhao; Qi Zhang; Yuanyuan Wang; Shipeng Li; Xiangyang Yu; Botao Wang; Ximo Wang
Journal:  Ann Transl Med       Date:  2021-07

Review 3.  Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities.

Authors:  Diana D Shi; Jimmy A Guo; Hannah I Hoffman; Jennifer Su; Mari Mino-Kenudson; Jaimie L Barth; Jason M Schenkel; Jay S Loeffler; Helen A Shih; Theodore S Hong; Jennifer Y Wo; Andrew J Aguirre; Tyler Jacks; Lei Zheng; Patrick Y Wen; Timothy C Wang; William L Hwang
Journal:  Lancet Oncol       Date:  2022-02       Impact factor: 54.433

Review 4.  Targeting cancer stem cells in drug discovery: Current state and future perspectives.

Authors:  Fang-Yu Du; Qi-Fan Zhou; Wen-Jiao Sun; Guo-Liang Chen
Journal:  World J Stem Cells       Date:  2019-07-26       Impact factor: 5.326

Review 5.  Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.

Authors:  Wei Mu; Zhe Wang; Margot Zöller
Journal:  Front Oncol       Date:  2019-12-16       Impact factor: 6.244

6.  MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.

Authors:  Cui Xu; Xiangxiu Qi
Journal:  J Clin Lab Anal       Date:  2020-06-26       Impact factor: 2.352

7.  Worst Pattern of Perineural Invasion Redefines the Spatial Localization of Nerves in Oral Squamous Cell Carcinoma.

Authors:  Yong Fu; Xinwen Zhang; Zhuang Ding; Nisha Zhu; Yuxian Song; Xiaoxin Zhang; Yue Jing; Yijun Yu; Xiaofeng Huang; Lei Zhang; Qingang Hu; Yanhong Ni; Liang Ding
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

Review 8.  MicroRNAs: emerging driver of cancer perineural invasion.

Authors:  Mei Zhang; Hong-Chun Xian; Li Dai; Ya-Ling Tang; Xin-Hua Liang
Journal:  Cell Biosci       Date:  2021-06-29       Impact factor: 7.133

9.  Tumor-neuroglia interaction promotes pancreatic cancer metastasis.

Authors:  Dan Su; Xiaofeng Guo; Leyi Huang; Huilin Ye; Zhiguo Li; Longfa Lin; Rufu Chen; Quanbo Zhou
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

Review 10.  The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.

Authors:  Xiaomeng Liu; Jin Xu; Bo Zhang; Jiang Liu; Chen Liang; Qingcai Meng; Jie Hua; Xianjun Yu; Si Shi
Journal:  Mol Cancer       Date:  2019-12-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.